Synopsis

In order to overcome barriers to adoption of neurostimulation technologies by patients and clinicians, we present here a minimally invasive needle placeable and fully implanted neurostimulator that is suitable for clinical imaging (U/S, X-Ray, MRI). The structural design and placement procedure of the injectable helical wire structure electrode (Injectrode) renders the device self anchoring and deliverable using a minimal number of components. Demonstrated are placements by clinicians on various nerve targets in animal and human models.

Disclosures

Stephan Nieuwoudt is employed by and owns equity in Neuronoff, Inc.
Amelia Howe is employed by and owns equity in Neuronoff, Inc.
Johanna Pearson is employed by Neuronoff, Inc.
Emily Szabo is employed by and owns equity in Neuronoff, Inc.
Morgan McGaughey is employed by and owns equity in Neuronoff, Inc.
Derrick Liu is employed by and owns equity in Neuronoff, Inc.
Shaher Ahmad is employed by and owns equity in Neuronoff, Inc.
Kip A. Ludwig is receiving funds from and owns equity in Neuronoff, Inc.
Hesham Elsharkawy owns equity in Neuronoff, Inc.
Amol Soin owns equity in Neuronoff, Inc.
Alaa Abd-Elsayed owns equity in Neuronoff, Inc.
Manfred Franke is employed by and owns equity in Neuronoff, Inc.
Andrew J. Shoffstall is receiving funds from and owns equity in Neuronoff, Inc.
This project is supported by Neuronoff Inc., NIH 1U18EB029251-01 Grant, and the DARPA EEI program. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense or the National Institutes of Health.

Manfred Franke PhD

CEO, Neuronoff, Inc

Appearances